Clinical Trials Browser

Hypoxia, Carcinoma, Renal Cell, Kidney Neoplasms

NCT02706197 2023-09-21

Oxygen Measurements in Subcutaneous Tumors by EPR Oximetry Using OxyChip

Phase NA Terminated

25 enrolled 9 charts

Hypoxia, Neoplasms

NCT01827709 2023-04-03

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

Phase NA Terminated

11 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia, Head and Neck Neoplasms

NCT02454842 2023-01-12

TH-4000

Phase 2 Terminated

21 enrolled

Thoracic

Hypoxia, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT03365076 2023-01-09

EXIPOX

Phase NA Terminated

1 enrolled

Genitourinary

Hypoxia, Motor Activity, Prostatic Neoplasms

NCT03466034 2020-01-29

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

Terminated

5 enrolled

Gynecologic

Hypoxia, Adenocarcinoma, Mucinous, Endometrial Neoplasms

NCT02233387 2019-03-08

HX4-cervix

Phase 2 Terminated

4 enrolled

Gynecologic

Hypoxia, Uterine Cervical Neoplasms

NCT02584400 2019-03-08

HX4 SD

Phase 2 Terminated

1 enrolled

CNSGastrointestinalGenitourinary

Hypoxia, Brain Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Rectal Neoplasms

NCT01210378 2019-02-15

Nitroglycerin

Phase 2 Terminated

47 enrolled

Thoracic

Hypoxia, Carcinoma, Non-Small-Cell Lung

NCT00159978 2015-05-07

Validation of 18F-MISO-PET and 18F-FLT-PET

Terminated

21 enrolled

Head & Neck

Hypoxia, Head and Neck Neoplasms

Clinical Trials

A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma

Oxygen Measurements in Subcutaneous Tumors by EPR Oximetry Using OxyChip

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

TH-4000

EXIPOX

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

HX4-cervix

HX4 SD

Nitroglycerin

Validation of 18F-MISO-PET and 18F-FLT-PET